Research Article| Volume 21, ISSUE 3, P679-690, September 2001

Advances in Medical Biological Defense Technology

      This paper is only available as a PDF. To read, Please Download here.
      Research and development on appropriate medical countermeasures have been in progress for many years for most of the commonly recognized biological threat agents. New advances in biotechnology have radically altered the traditional threat of biological agents because organisms can be modified to have properties of virulence or toxicity not found naturally. This article describes some of the advanced biotechnologic approaches used to produce medical countermeasures against the threats of biowarfare and bioterrorism.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Alexander J: Biological Warfare Defense and Biological Systems. Presented at the Defense Advanced Research Projects Agency 20th Systems and Technology Symposium (DARPATech), Denver, CO, June 7-10, 1999

        • Belgrader P.
        • Smith J.K.
        • Weeden V.W.
        • et al.
        Rapid PCR for identity testing using a battery-powered miniature thermal cycler.
        J Forensic Sci. 1998; 43: 315-319
        • Committee on R&D Needs for Improving Civilian Medical Response to Chemical and Biological Terrorism Incidents
        Detection and measurement of biological agents chemical and biological terrorism.
        in: Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response. National Academy Press, Washington, DC1999: 78-96
      2. Defense Advanced Research Projects Agency: Biological warfare defense. Available at

      3. Eitzen E.W. Culpepper R.C. Cieslak T.J. Medical Management of Biological Casualties Handbook. ed 3. US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD1999
        • Franz D.R.
        • Jahrling P.B.
        • Friedlander A.M.
        • et al.
        Clinical recognition and management of patients exposed to biological warfare agents.
        JAMA. 1997; 278: 399-411
      4. Goldblatt MJ: DSO Overview. Presented at the Defense Advanced Research Projects Agency 21st Systems and Technology Symposium (DARPATech), Dallas, TX, September 6-8, 2000

        • Henchal E.A.
        • Teska J.D.
        • Ezzell J.W.
        Responding to biological terrorism: A role for the clinical laboratory.
        Clin Lab News. 2000; 26: 14-18
        • Ibrahim M.S.
        • Lofts R.S.
        • Jarling P.B.
        • et al.
        Real-time microchip PCR for detecting singlebase differences in viral and human DNA.
        Anal Chem. 1998; 70: 2013-2017
        • Kasianowicz J.J.
        • Brandin E.
        • Branton D.
        • et al.
        Characterization of individual polynucleotide molecules using a membrane channel.
        Proc Natl Acad Sci U S A. 1996; 93: 13770-13773
        • Meller A.
        • Nivon L.
        • Brandin E.
        • et al.
        Rapid nanopore discrimination between single polynucleotide molecules.
        Proc Natl Acad Sci U S A. 2000; 97: 1079-1084
      5. Morse SS: Biological warfare defense. Presented at the Defense Advanced Research Projects Agency 20th Systems and Technology Symposium (DARPATech), Denver, CO, June 7-10, 1999

        • Morse S.S.
        Defending against biological warfare: Programs of Defense Advanced Research Projects Agency (DARPA).
        in: Raymond S.U. Technology and Arms Control for Weapons of Mass Destruction. New York Academy of Sciences, New York1998: 23-28
      6. Murray P.R. Manual of Clinical Microbiology. ed 7. American Society for Microbiology, Washington, DC1999
      7. North Atlantic Treaty Organization (NATO) Handbook on the Medical Aspects of NBC Defensive Operations, AmedP-6(B), Part II Biological. Departments of the Army, Navy, and Air Force, 1996

        • Northrup M.A.
        • Benett B.
        • Hadley D.
        • et al.
        A miniature analytical instrument for nucleic acids based on micromachined silicon reaction chambers.
        Anal Chem. 1998; 70: 918-922
        • O’Connor S.M.
        • Andreadis J.D.
        • Shaffer K.M.
        • et al.
        Immobilization of neural cells in three-dimensional matrices for biosensor applications.
        Biosens Bioelectron. 2000; 14: 871-881
        • Pancrazio J.J.
        • Whelan J.P.
        • Borkholder D.A.
        • et al.
        Development and application of cell-based biosensors.
        Ann Biomed Eng. 1999; 27: 697-711
      8. Rudolph AS: Tissue-based biosensors. Defense Advanced Research Projects Agency. Biological Warfare Defense. Available at

      9. Sidell FR, Takafuji ET, Franz DR (eds): Textbook of Military Medicine. Part I, Warfare, Weaponry, and the Casualty: Medical Aspects of Chemical and Biological Warfare. Washington, DC, Office of the Surgeon General, Department of the Army, United States of America, 1997

      10. Snyder J.W. Cumitech 33: Biological Agents Associated with Bioterrorism. American Society for Microbiology, Washington, DC2000
        • Whalen R.G.
        • Davis H.L.
        DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen.
        Clin Immunol Immunopathol. 1995; 75: 1-12